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The rise in blood pressure during an acute aversive stress has been suggested to involve activation of angiotensin type 1A receptors
(AT1ARs) at various sites within the brain, including the rostral ventrolateral medulla. In this study we examine the involvement of
AT1ARsassociatedwitha subclassof sympatheticpremotorneuronsof the rostral ventrolateralmedulla, theC1neurons.Thedistribution
of putative AT1AR-expressing cells was mapped throughout the brains of three transgenic mice with a bacterial artificial chromosome-
expressing green fluorescent proteinunder the control of theAT1ARpromoter. Theoverall distribution correlatedwith that of theAT1ARs
mapped by other methods and demonstrated that the majority of C1 neurons express the AT1AR. Cre-recombinase expression in C1
neurons of AT1AR-floxed mice enabled demonstration that the pressor response to microinjection of angiotensin II into the rostral
ventrolateralmedulla is dependent upon expression of theAT1AR in these neurons. Lentiviral-induced expression ofwild-typeAT1ARs in
C1 neurons of global AT1AR knock-outmice, implantedwith radiotelemeter devices for recording blood pressure,modulated the pressor
response to aversive stress.Duringprolonged cage-switch stress, expressionofAT1ARs inC1neurons inducedagreater sustainedpressor
response when compared to the control viral-injected group (22 4 mmHg for AT1AR vs 10 1 mmHg for GFP; p 0.001), which was
restored toward that of the wild-type group (28 2 mmHg). This study demonstrates that AT1AR expression by C1 neurons is essential
for the pressor response to angiotensin II and that this pathway plays an important role in the pressor response to aversive stress.
Introduction
The response to stress involves coordinated activation of the au-
tonomic nervous system and the hypothalamic–pituitary–adre-
nal axis (Ulrich-Lai and Herman, 2009). While stress responses
are essential physiology, there is a growing recognition that aber-
rant, or sustained, stress exposure is detrimental and can lead to
the development of hypertension (Esler, 2009).
Both systemic and brain angiotensin systems play important
roles in the responses to stress (Saavedra and Benicky, 2007).
Treatment of hypertensive patients with an angiotensin convert-
ing enzyme inhibitor lowers blood pressure (BP) and reduces the
pressor response tomental stress (KahanandEliasson,1999).Exper-
imental animal studies have demonstrated a role for brain angioten-
sin II (AngII), acting through its type 1A receptor (AT1AR), in the
neuroendocrine and autonomic response to stress. This is particu-
larly clear for corticotrophin-releasing hormone release induced by
AT1AR stimulation in the hypothalamus (Aguilera et al., 1995; Ar-
mando et al., 2001). Studies inmice also implicate the AT1AR in the
pressor response to aversive stress, as global genetic deletion of the
AT1AR leads to an attenuated pressor response to aversive stress, but
not to appetitive stimuli (Chen et al., 2009).
The rostral ventrolateral medulla (RVLM) is a critical site for
regulation of sympathetic vasomotor activity (Dampney, 1994)
and is proposed to be involved in the cardiovascular response to
aversive stress, although this involvement remains controversial
(Vianna and Carrive, 2010). Studies conducted in conscious rab-
bits showed that the stress-induced pressor response consists of at
least two components acting in the RVLM—an initial response,
mediated by glutamate, followed by a sustained response (Mayo-
rov andHead, 2002, 2003). Local microinjections of AT1R antag-
onists in the RVLM attenuate the sustained pressor response
(Mayorov and Head, 2003). These observations indicate that the
RVLMmaybe an importantnode connecting the effects ofAngII on
stimulation of the autonomic nervous system in aversive stress.
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The RVLM contains moderate to high densities of AT1Rs in
most species, including humans (Allen et al., 1998). The RVLM
contains at least two major subtypes of presympathetic neurons
based on their expression of catecholamine synthetic enzymes.
One group, the C1 neurons, expresses all of the enzymes required
to synthesize adrenaline (Phillips et al., 2001), whereas the other
group expresses none of these enzymes and is referred to as
non-C1 neurons (Lipski et al., 1995; Schreihofer and Guyenet,
1997). The relative involvement of these different cell groups in
the pressor response to aversive stress remains unclear. Recently,
it was shown that C1 neurons of the RVLM have the capacity to
induce a sympathetically mediated increase in BP (Abbott et al.,
2009) and that expression of the AT1AR in C1 neurons of AT1AR
knock-out (AT1AR
/) mice reinstates the sympathoexcitation
induced by AngII in the RVLM (Chen et al., 2010). Therefore, the
aim of this current study is to examine the effect of transgenic
expression of the AT1AR in the C1 neurons of the RVLM on the
cardiovascular responses to acute aversive stress in conscious
AT1AR
/mice.
Materials andMethods
Experiments followed the Australian National Health and Medical Re-
search Council Code of Practice for the Care and Use of Animals for
Scientific Purposes and were approved by the University of Melbourne
and the Alfred Medical Research Education Precinct Animal Ethics
Committees. AT1AR
/ mice and their own control strain (AT1AR
/)
were bred in the animal facilities at the Baker IDI Heart and Diabetes
Research Institute (Melbourne, VIC, Australia). Mice were originally
obtained from Prof. T. Walther (Charite´, Berlin, Germany), who pro-
duced F2 generation crosses of (129 C57BL/6J) F1 AT1AR
/ parents
maintained on a C57Bl/6 background (Gembardt et al., 2008).Mice with
a conditional Agtr1a allele (AT1AR
fl/fl) were generated using standard
gene targeting methods (Gurley et al., 2011) and obtained from Dr. S.
Gurley and Prof. T. Coffman (Duke University, Durham, NC). They
were maintained as a homozygote line on a C57BL/6 background at the
Florey Neurosciences Institute (University of Melbourne, Melbourne,
VIC, Australia). Cre-recombinase (Cre) reporter mice (ROSA26-eYFP,
where eYFP is enhanced yellow fluorescent protein) were obtained from
Prof. F. Costantini, Columbia University, New York, NY (Srinivas et al.,
2001) and maintained at the Florey Neurosciences Institute, University
of Melbourne. All mice were genotyped using standard PCR protocols.
All mice were maintained under 12 h light/dark cycle (lights on from 6
A.M. to 6 P.M.) with ad libitum access to standard chow and water.
Brains from three male adult mice, in which enhanced green fluorescent
protein (GFP) and a polyadenylation signal were inserted before theATG
start codon of the Agtr1a gene (pAT1AR-GFP), were obtained from the
GenSat BAC transgenic project (GENSAT). These had been deeply anes-
thetized, perfusedwith 4%paraformaldehyde, and stored in 20% sucrose
solution for shipping from theUnited States toAustralia. The brainswere
frozen in isopentane on dry ice and stored at80°C before histological
processing of serial sections taken every 300 m throughout the entire
neuraxis.
Lentiviral injection in RVLM
Replication-deficient lentiviruses with transgene expression under the
control of a synthetic phox2-selective promoter (PRSx8) were injected
bilaterally into the RVLM of anesthetized mice (80 mg/kg ketamine, 10
mg/kg xylazine, i.p.) (Chen et al., 2010). Before surgery mice, were in-
jected with a nonsteroidal analgesic (Carprofen, 5 mg/ml, 0.5 mg/100 g,
i.p; Norbrook Laboratories) and anesthesia induced by inhalation of
isoflurane (Rhodia Australia) in a sealed container. Three different vi-
ruses were used that induced expression of GFP (Lv-PRSx8-GFP; titer,
2  1011 viral particles per milliliter), wild-type hemagglutinin-tagged
AT1AR (Lv-PRSx8-AT1AR; titer, 3.7 10
11 viral particles per milliliter),
or Cre (Lv-PRSx8-Cre; titer, 3.9  1010 viral particles per milliliter). A
detailed description of the methods used to generate and characterize
these viruses, including the demonstration that injection of Lv-PRSx8-
AT1AR-induced expression of AT1ARs capable of altering neuronal activ-
ity upon stimulation, has been published previously (Chen et al., 2010).
Anesthetized mice were placed in a stereotaxic apparatus (Benchmark
stereotaxic instruments; MyNeurolab) in a prone position. The position
of the head was adjusted so that the skull surface was horizontal. A
midline incision was made over the occipital bone, and portions of the
bone overlying the cerebellum were carefully removed with a dental drill
while keeping the lambdoid suture intact. The lambdoid and midline
sutures served as reference points for rostrocaudal and lateral coordi-
nates, respectively. Microinjections (100 nl per site) were made to the
RVLM, 1.2 mm lateral to the midline and 5.3 mm ventral to the dorsal
surface of the brain at three rostrocaudal coordinates, 1.7, 1.9, and 2.1
mm caudal to lambda. Microinjections were made through pulled glass
micropipettes (1B100F-4; World Precision Instruments), with tip diam-
eters of 30–50m. Solutions were ejected using pressurized nitrogen gas
delivered via a pneumatic pressure device (SYS-PV820; World Precision
Instruments), and volumes were determined by observation of move-
ment of the fluid meniscus using a monocular microscope fitted with an
eye-piece graticule (Cole-Parmer). Upon completion of the injection,
the incision was closed with surgical silk stitches. Mice received atipam-
ezole hydrochloride (1 mg/kg, i.p.; Antisedan; VMS Supplies) to reverse
the anesthesia. Each mouse was housed individually. ROSA26-eYFP
mice were injected unilaterally with Lv-PRSx8-Cre. AT1AR
fl/fl mice
were injected bilaterally with either Lv-PRSx8-Cre or Lv-PRSx8-GFP.
AT1AR
/mice were injected bilaterally with either Lv-PRSx8-AT1AR or
Lv-PRSx8-GFP and used in long-term studies to assess cardiovascular
control and stress responses.
Verification of viral-induced Cre expression
Approximately 4 weeks after microinjection of Lv-PRSx8-Cre into the
RVLM, the ROSA26-eYFP mice (n  3) were deeply anesthetized using
the anesthetic protocol described above and perfused with 4% parafor-
maldehyde, and the brains removed for histological processing.
RVLM microinjections in anesthetized mice
Approximately 4 weeks after bilateral microinjection of Lv-PRSx8-Cre
(n 6) or Lv-PRSx8-GFP (n 6) into the RVLM, AT1AR
fl/fl mice were
anesthetized by inhalation of isoflurane (1.8–2%) to study the acute
cardiovascular response to microinjection of glutamate and AngII into
the RVLM. Standard protocols were used as described previously (Chen
et al., 2010). Briefly, mice were maintained at a rectal temperature of
37°C using a servocontrolled heating blanket, tracheotomized, and arti-
ficially ventilated (UGO Basile mouse ventilator 28025) with oxygen.
End-tidal CO2 was measured (CWE) and maintained between 2.5 and
3.5%. The left carotid artery was cannulated for measurement of BP
(Neurolog System; Digitimer), and heart rate (HR) was derived from the
digitized signal (Cambridge Electronic Design). Fluid balance was main-
tained by subcutaneous injection of Hartmann’s solution (Baxter
Healthcare). Mice were placed in a stereotaxic frame, as described for
injections above, and either glutamate (10 nl of a 10 mM solution) or
AngII (50 nl of a 1 mM solution; AusPep) were microinjected into the
RVLM. Several injections of glutamate weremade to identify the site that
produced an immediate rise in arterial pressure. Injections were made
independently into both sides of the brain, with a period of at least 30min
elapsing between AngII microinjections. The AngII solution contained a
1% concentration of rhodamine-labeled microspheres (Invitrogen) to
enable histological identification of the injection site postmortem. At the
completion of the experiment, mice were deeply anesthetized and per-
fused with 4% paraformaldehyde, and the brains removed for histologi-
cal analysis of GFP or CD68 expression, to localize viral injection sites,
and rhodamine-labeled microspheres.
Cardiovascular and stress responses in RVLM Lv-PRSx8-AT1A
R-injected knock-out mice
Telemetry implantation. Under isoflurane anesthesia (Abbott Laborato-
ries), AT1AR
/ (n  12) and AT1AR
/ (n  6) mice were implanted
with PA-C10 telemeters (Data Sciences International) in the left carotid
artery as described previously (Butz and Davisson, 2001). Both before
surgery and on the first day following surgery, each mouse received pain
relief (Carprofen, 0.5mg/100 g, i.p.; Norbrook). Eachmouse received 0.5
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ml saline subcutaneously at the time of operation and then again 24 h
after operation. Mice were kept warm on a heat pad andmonitored until
fully recovered from anesthesia. Each mouse was housed individually,
and the mouse cages were half kept on a heated surface for 24–48 h to
assist in their thermoregulation. Twoweeks after telemetry implantation,
baseline 24 h recordings of BP were made, and on the next day, bilateral
injections of either Lv-PRSx8-AT1AR (n 7) or Lv-PRSx8-GFP (n 5)
were made into the RVLM of AT1AR
/mice.
Cardiovascular measurements. Pulsatile arterial pressure was recorded
continuously, sampled at 1 kHz using an analog-to-digital data acquisi-
tion card (PCI-8024E;National Instruments), and the beat-to-beatmean
arterial pressure (MAP) and HR were detected on-line and analyzed
using a program written in Labview (Head et al., 2001; Navakatikyan et
al., 2002). An index of locomotor activity was obtained by monitoring
changes in the received signal strength, which occurred uponmovement
of the animal. For detection of activity, the mouse had to move location.
Therefore, with the transmitter implanted subcutaneously, slight move-
ments during grooming or eating were not registered as activity. Systolic,
mean, and diastolic BP, pulse interval, and locomotor activity were
stored in text format on an IBM-compatible computer. Baseline cardio-
vascular parameterswere observed for an additional 4weekswith record-
ings over a consecutive 24 h period every week.
Autonomic activity was assessed by monitoring spontaneous changes
in BP andHR. Beat-to-beatMAP andHRwere analyzed between 10A.M.
and 1 P.M. (during the inactive period) on 2 consecutive days. The au-
topower and cross-power spectra were calculated for multiple overlap-
ping (by 50%) segments of MAP and HR using fast Fourier transform
(Head et al., 2001). The average value used as the estimate of the barore-
flex sensitivity in this study is the mid-frequency band (0.3–0.5 Hz) and
relates to autonomic function (Janssen and Smits, 2002). Other fre-
quency bands analyzed were the low-frequency band (0.08–0.3 Hz) and
the high-frequency band (0.5–3Hz). Normalized power was obtained by
dividing the cumulative power within each frequency band by the total
power (Head et al., 2004; Baudrie et al., 2007).
Stress test protocols. Blood pressure, HR, and locomotor activity were re-
corded continuously throughout the experiment. Restraint and feeding tests
were performedon the sameday but separated by at least 60minof recovery
period (or until BP returned to baseline levels) with a quiet rest period of at
least 5min before the commencement of each test. To test the reproducibil-
ity of stress responses, all tests were repeated, in random order, on the fol-
lowing day. As there was no difference in cardiovascular responses to stress
on Experimental Days 1 and 2, the data were pooled and treated as repeated
measures for subsequent analysis. The cage-switch test was conducted ap-
proximately 1 week later on the final day of experimental protocol. All mice
were then perfused for immunohistochemistry.
Feeding test. A piece of almond (0.5 g), a novel palatable stimulus, was
placed in thehomecage.This is accompaniedbymarked increases inBPand
HR (Jackson et al., 2007; Chen et al., 2009). The mouse was observed from
when it commenced eating until when it ceased eating. The average change
inMAP and HR over the first 5 min was used to estimate the magnitude of
cardiovascular response to feeding (DeMatteo et al., 2006).
Restraint stress. Mice were placed in a cylindrical Plexiglas container
used for tail cuff BP measurements (length, 135 mm; diameter, 50 mm;
Harvard Apparatus). The sliding plate was moved to confine the mouse
without applying physical pressure to it. The restrainedmouse was left in
the restrainer in its home cage for 5 min before being released.
Cage-switch stress.All mice were placed in a clean cage andmaintained
in that cage without further cleaning for at 7 d before cage-switch stress.
This is a model of acute psychosocial stress (Lee et al., 2004). During the
light period on the day of the study, 1 h of baseline recording was made
with themice undisturbed in their home cage. Themicewere then placed
into a cage occupied previously (for 7 d) by a different male mouse for a
period of 1 h. The pressor response is reproducible, takes over 90 min
after beginning cage-switch test to subside, and is accompanied by sig-
nificant increases inHR andmotor activity inmice (Lee et al., 2004). The
cage-switch test was conducted approximately 1 week after the restraint
and feed tests on the final day of the experimental protocol. Allmice were
then anesthetized and perfused for immunohistochemistry processing.
Data analysis. Cardiovascular responses to microinjection of gluta-
mate and AngII into the RVLM of viral-injected AT1AR
fl/fl mice were
measured as the 10 s average maximal response after microinjection of
either glutamate or AngII and compared to a 60 s preinjection control
period. For analysis of the responses to restraint and novel almond feed-
ing stimuli, 30 s averages of MAP, HR, and activity signals were deter-
mined for the period 5 min before the stimulus, 5 min during the
stimulus, and 5 min after the stimulus. For analysis of the responses to
dirty-cage-switch stress, 10 min averages of MAP, HR, and activity sig-
nals were determined for the period 1 h before the cage switch and 1 h
during the cage switch.
Statistical analysis. All variables are presented as mean  SEM.
Changes in arterial pressure and heart rate in response to glutamate and
AngII microinjection into the RVLM were compared by two-way
repeated-measures ANOVA followed by a pairwise multiple comparison
(Holm–Sidak method; SigmaPlot version 11; Systat Software). Cardio-
vascular data from the telemetered mice were analyzed by a split-plot
repeated-measures ANOVA where the between-group sums of squares
due to change over time or stress were used to compare the differences
between Lv-PRSx8-GFP- and Lv-PRSx8-AT1AR-injected AT1AR
/
mice and control, uninjected AT1AR
/ mice. For the 24 h recordings
over 33 d before and after microinjection, individual between-group
Bonferroni-adjusted contrasts weremade to compare values at Days 0, 7,
13, 20, 27, and 33. The degrees of freedom of the ANOVA were adjusted
by the Greenhouse–Geisser coefficient to reduce the interdependence of
repeated variables. Values were considered significant at p 0.05.
Histological processing. At the completion of each experimental proto-
col, anesthesia was induced in all mice by inhalation of isoflurane and
then injection of ketamine/xylazine as described above. They were per-
fused through the heart with saline (0.9%NaCl) followed by a solution of
4% formaldehyde in 0.1 mol/L sodium phosphate buffer. The brains
were removed, postfixed in formaldehyde for 1–2 h, and then cryopro-
tected in 20% sucrose overnight at 4°C. Brainstem sections were cut on a
cryostat (Microm International) and serial coronal 40 m sections were
collected in four series and stored in cryoprotectant [30% (w/v) sucrose,
30% (v/v) ethylene glycol, 1% (w/v) polyvinyl-pyrrolidone in 50 mM
phosphate buffer, pH 7.2] until immunohistochemical staining as de-
scribed previously (Llewellyn-Smith et al., 2003; Chen et al., 2010).
Brains from pAT1AR-GFP, Lv-PRSx8-GFP-injected AT1AR
/ and
AT1AR
fl/fl and Lv-PRSx8-Cre-injected ROSA26-eYFP mice were pro-
cessed for immunohistochemical double staining of tyrosine hydroxylase
(TH) and GFP. The Lv-PRSx8-AT1AR-injected AT1AR
/mice and Lv-
PRSx8-Cre-injected AT1AR
fl/flmice were processed for TH and the mac-
rophage marker CD68, which is a reliable marker for the injection site
(Card et al., 2006). The primary antibodies were rat anti-mouse CD68 (1:1000;
AbD Serotec), rabbit anti-TH (1:500;Millipore Bioscience Research Reagents),
and chicken anti-GFP (1:1000; Millipore Bioscience Research Reagents). The
secondary antibodies were Alexa Fluor 488-conjugated goat anti-chicken (1:
200), Cy3-conjugated donkey anti-rabbit (1:200), Dylight 549 goat anti-rat (1:
200; AbD Serotec), or Alexa Fluor 488 goat anti-rabbit (1:200; Vector
Laboratories), as required. Immunofluorescencewas imagedusing anAxio Im-
agerD.1microscopeconnectedtoanAxioCamMRc5digitalcamera(bothfrom
Zeiss) andmappingperformedwith reference to themousebrainatlas (Paxinos
andFranklin, 2004).
Results
Distribution of AT1AR-expressing neurons in the mouse
brain
The distribution of neurons expressing GFP in the pAT1AR-GFP
mouse was examined throughout the brain in serial sections,
taken every 300 m, in three mice. The distribution of GFP-
expressing cells was consistent between all the mice examined.
Green fluorescent protein labeling was found in the soma and
processes of cells with neuronalmorphology, and no labeling was
obvious in cells that were morphologically similar to astrocytes or
glia. The distribution of GFP immunoreactivity throughout the
brain was consistent with previous studies examining AT1R distri-
bution in themouse brain (Jenkins et al., 1997) with no evidence of
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ectopic expression. Some regions, such as the area postrema, were
expected to displayGFP immunoreactivity but did not. The cerebel-
lum and spinal cord were not examined in this study.
Forebrain
A dense population of GFP-labeled neurons occurred in the dor-
sal lateral septal nucleus (Fig. 1A), vascular organ of the lamina
terminalis (Fig. 1B), median preoptic nucleus (Fig. 1B,C), and
subfornical organ (Fig. 1D). Numerous GFP-expressing neurons
were observed in the parvocellular subdivisions of the hypotha-
lamic paraventricular nucleus (Fig. 1G), the periventricular hy-
pothalamic nucleus (Fig. 1G), and the suprachiasmatic nucleus
(Fig. 1H). Within the hypothalamic paraventricular nucleus, no
colocalization was observed between GFP and TH, indicating
that the AT1AR-expressing cells were not part of the A12 dopa-
minergic cell group (data not shown). ScatteredGFP-labeled cells
occurred in the anterior hypothalamic area (Fig. 1E), lateral hypo-
thalamic area (Fig. 1F), dorsal medial hypothalamic area (data not
shown), and arcuate nucleus. Scattered neurons in the caudate–pu-
tamen (data not shown) and central nucleus of the amygdala (Fig.
1I) also showed GFP labeling. No GFP labeling was observed in the
hippocampus, thalamic nuclei, supraoptic nucleus, or magnocellu-
lar component of paraventricular hypothalamic nucleus.
Midbrain and pons
A distinct cluster of GFP-positive cells occurred in the dorsomedial
interpeduncular nucleus of the pons (Fig. 1B), and scattered GFP-
positive cellswere seen in the lateral superior olive (data not shown).
Medulla
Neurons expressing GFP were observed in the dorsal medulla in
the nucleus of the solitary tract (Fig. 1 J) and the dorsal motor
nucleus of the vagus (data not shown). In addition, GFP-positive
terminals were prominent within the nucleus of the solitary tract.
Surprisingly, noGFP labelingwas observed in area postrema. The
nucleus ambiguus contained a compact group of GFP-expressing
cells (data not shown). GFP-labeled neurons were also present
throughout the caudal nucleus of the spinal trigeminal tract (Fig.
1K). Within the RVLM (Fig. 2A), caudal ventrolateral medulla
(data not shown), and nucleus of the solitary tract (data not
shown), the majority of GFP-positive cells also expressed TH
immunoreactivity (Fig. 2B) and thus represent the C1, A1, and
A2 cell groups, respectively. A small proportion (10%) of GFP-
labeled cells that were non-TH-immunoreactive were observed
in both the RVLM (Fig. 2A) and caudal ventrolateral medulla.
Lentiviral-induced Cre expression and conditional knock-out
Microinjection of Lv-PRSx8-Cre into the RVLM of
ROSA26-eYFP mice
To verify the cell selectivity and level of Cre-recombinase expres-
sion when delivered as a lentiviral transgene, Lv-PRSx8-Cre was
microinjected into the RVLM of ROSA26-eYFP mice. Approxi-
mately 4 weeks after injection, robust eYFP expression was ob-
served within the RVLM, which predominantly (90%)
colocalized with TH immunoreactivity (Fig. 2D–F).
Figure 1. A–K, Photomicrographs of coronal sections at different levels of the neuraxis showing GFP immunoreactivity in pAT1AR-GFP transgenic mice. The white cell profiles show GFP
expression. Scale bars: 100m. ac, Anterior commissure; AHA, anterior hypothalamic area; cc, central canal; CeA, central nucleus of the amygdala; LH, lateral hypothalamus; LSD, dorsal subnucleus
of the lateral septal nucleus; LV, lateral ventricle; MnPO, median preoptic nucleus; NTS, nucleus of the solitary tract; OVLT, organum vasculosum of the lamina terminalis; PVN, hypothalamic
paraventricular nucleus; SCh, suprachiasmatic nucleus; SFO, subfornical organ; Sp5C, caudal part of the spinal trigeminal nucleus; 3V, third ventricle; 4V, fourth ventricle.
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Response to RVLM microinjection of angiotensin II following
cell-selective AT1AR deletion
Four weeks after bilateral microinjection of Lv-PRSx8-Cre or
Lv-PRSx8-GFP into the RVLM of AT1AR
fl/fl mice, there was no
difference in baseline BP or HR under isoflurane (1.8–2.0%)
anesthesia [GFP vs Cre: MAP, 86 8mmHg and 76 5mmHg;
HR, 538  30 beats per minute (bpm) and 518  16 bpm; not
significant]. Microinjection of 10 mM glutamate (10 nl) resulted
in a robust and rapid increase in BP (Fig. 2 I) when localized
within the RVLM. Comparison of maximal responses re-
vealed no difference between Lv-PRSx8-Cre- and Lv-PRSx8-
GFP-injected animals. Microinjection of 1 mM AngII (50 nl)
similarly resulted in a robust increase in BP, although with a
longer time to reachmaximum than glutamate, in the Lv-PRSx8-
GFP-injected animals (Fig. 2G). In contrast, the response to
AngII was dramatically attenuated in Lv-PRSx8-Cre-injected
AT1AR
fl/fl mice (not significant compared to baseline) (Fig.
2H). Postmortem analysis revealed that all microinjections
included in this study were within 50–400 m of the caudal
pole of the facial nucleus and correlated with the distribution
of TH- immunoreactive neurons.
Behavioral experiments
Verification of lentiviral injection sites
At the completion of the cage-switch stress tests, the mice were
killed, and their brains were removed for histology. Verification
of lentiviral-induced GFP expression was performed postmor-
tem by immunohistochemistry with colocalization with TH (Fig.
3A–C). The site of Lv-PRSx8-AT1AR injections was visualized by
examination ofCD68 expression and colocalizedwithTH immu-
nohistochemistry (Fig. 3D–F). For allmice included in this study,
the microinjections were within the region of TH-expressing
neurons and within 500mof the caudal pole of the facial motor
nucleus. Schematic coronal sections ofmousemedulla oblongata
modified from the atlas of Paxinos and Franklin (2004), showing
the range of all viral microinjections in mice from this study, are
included (Fig. 3G). Previous studies using identical protocols
have quantified expression of the AT1R binding site density in
RVLM following lentiviral injections inAT1AR
/mice (Chen et
al., 2010). Those studies indicated that transgene expression re-
sulted in an increase of 97% AT1AR expression above the level of
endogenous receptor expression in the RVLM of a wild-type
Figure 2. A–F, Photomicrographs of fluorescence immunohistochemistry images showing GFP (A,D), TH (B, E), and themerged images (C, F ) at the level of the RVLM froma pAT1AR-GFPmouse
(A–C) and a ROSA26-eYFPmouse injected with Lv-PRSx8-Cre virus (D–F ). Within the RVLM of a pAT1AR-GFPmouse the majority of GFP-expressing neurons also expresses TH. The arrows point to
the few neurons that are clearly GFP positive that do not express TH. Following microinjection of Lv-PRSx8-GFP into the RVLM of a ROSA26-eYFPmouse, the majority of YFP expression occurs in
TH-expressing cells. G,H, Arterial pressure (AP; in millimeters mercury), MAP (in millimeters mercury), and HR (bpm) were recorded in anesthetized AT1AR
fl/flmice injected4 weeks earlier with
Lv-PRsx8-GFP (G) or Lv-PRSx8-Cre (H ) into the RVLM. Microinjection of AngII into the RVLM (arrows) induced an increase in MAP and HR in the Lv-PRsx8-GFP-injected animals that was similar to
that observedpreviously inwild-typemice. This responsewasmarkedly attenuated in Lv-PRSx8-Cre injectedmice. I, Thegroupeddata (n6 for eachgroup) showing the response tomicroinjection
of glutamate and AngII into the RVLM of these animals. Scale bars: 100. ns, No significant difference between groups. ***p 0.001.
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mouse. This remains less than the level of
endogenous AT1R expression in other
brain regions such as the nucleus of the
solitary tract.
Average body weights of Lv-PRSx8-
GFP- and Lv-PRSx8-AT1AR-injected
AT1AR
/micewerenot different through-
out the experiment (Week 0, 23.2 1.0 g vs
23.3 0.6 g; Week 5, 24 1.2 g vs 24.0
0.7 g, respectively). The AT1AR
/ mice
weighed 30 0.5 g.
Basal cardiovascular measurements
The 24 h average basal MAP and HR were
similar between both groups of AT1AR
/
mice at Week 0, before RVLM microinjec-
tion of Lv-PRSx8-GFPor Lv-PRSx8-AT1AR
(Fig. 4). Seven days after viral microinjec-
tions, Lv-PRSx8-GFP mice had a transient
increase in MAP and HR compared to Lv-
PRSx8-AT1AR mice (100  1 mmHg vs
83 1 mmHg, p 0.001; 585 6 bpm vs
489 5 bpm, p 0.001). At all other times
there was no difference in 24 h average
MAP, HR, or locomotor activity between
groups (Fig. 4).
A distinct circadian pattern of MAP,
HR, locomotor activity, and time spent
active was observed in both groups, char-
acterized by higher values of these param-
eters during the night (Fig. 5). Analysis of
the circadian variation of BP showed
that at Weeks 3–5 the Lv-PRSx8-AT1AR-
injectedmice had a small decrease inMAP
during the inactive, light period (6.6 
3.3 mmHg; p  0.05), with no change in
the dark period (2.8 3.4mmHg) (Fig.
5B). There was no change in any of the
othermeasured parameters. At the time of
the stress responses, the AT1AR
/ mice
had a significantly higher resting blood
pressure and heart rate compared to the
Lv injected AT1AR
/ mice (MAP,
AT1AR
/, 108  0.2 mmHg; Lv-PRSx8-
GFP, 77  1 mmHg; Lv-PRSx8-AT1AR,
74  1 mmHg; HR: AT1AR
/, 508  7
bpm; Lv-PRSx8-GFP, 435 10 bpm; Lv-
PRSx8-AT1AR, 411 11 bpm).
Autonomic activity was assessed indirectly by monitoring
spontaneous changes in BP andHRusing power spectral analysis.
The average power of MAP and HR variability in all frequency
spectral bands was similar in all mice before RVLM microinjec-
tions of Lv-PRSx8-AT1AR or Lv-PRSx8-GFP during the light pe-
riod (inactive period) (Table 1). The average power of HR
variability in the low-, mid-, and high-frequency bands during
the inactive period was similar between Lv-PRSx8-AT1AR and
Lv-PRSx8-GFP RVLM-microinjected mice (Table 1). However,
the totalpowerofHRvariability (theaverageacross low,middle, and
high frequencies)was smaller in theLv-PRSx8-AT1AR- compared to
Lv-PRSx8-GFP-microinjected mice at Day 33 (926 126 bpm2
vs 1538  158bpm2; p  0.05) (Table 1). The spontaneous
baroreflex sensitivity (midfrequency of the HR variability spec-
tra) was similar before and after viral microinjections, as well
as between Lv-PRSx8-AT1AR and Lv-PRSx8-GFP at Day 33
(Table 1).
Behavioral tests
Cage-switch stress
Placing amale mouse in a cage occupied previously for 1 week by
another male mouse is a strong aversive stressor that induces an
increase in BP that is maintained for at least 90 min. All mice
showed similar initial pressor, tachycardic, and activity responses
to the cage-switch stress (Fig. 6). Differences between cohorts
were observed in the sustained phase of the response, which we
measured as the average value over the entire 60 min cage-switch
period. Lv-PRSx8-GFP mice showed a significant reduction in
the sustained component of these responses, indicating that their
BP and HR responses returned to baseline levels more quickly
than the AT1AR
/ mice (Fig. 6). Reexpression of the AT1AR in
Figure 3. Photomicrographs of images obtained from fluorescence immunohistochemistry.A–C, The top row shows immuno-
histochemistry for GFP produced following microinjection of Lv-PRSx8-GFP in the RVLM (A) with colocalization of TH (B) on the
same section and the merged image (C). D–F, The next row shows immunohistochemistry for the macrophage marker CD68 (D)
fromananimal injectedwith Lv-PRSx8-AT1AR in theRVLM,with colocalizationof THon the same section (E) and themerged image
(F ). Correlation of the two markers indicates correct microinjection placement. Scale bar: A (for A–F ), 100 m. G, Schematic
diagramsof coronal sections of themousemedulla oblongata [modified fromtheatlas of Paxinos andFranklin (2004)] showing the
range of all viral microinjections in the AT1AR
/mice included in this study. The open areas are RVLM Lv-PRSx8-GFP-injected
AT1AR
/mice, and the blocked areas are RVLM Lv-PRSx8-AT1AR-injected AT1AR
/mice. Some injections from different mice
were in identical regions and are represented only by a single symbol. The numbers represent the distance from bregma. Amb,
Nucleus ambiguus; 7N, facial motor nucleus; Sp5, spinal trigeminal tract; IO, inferior olivary nucleus.
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C1 neurons induced a significantly greater sustained pressor re-
sponse to the 1 h period of dirty-cage-switch stress compared to
Lv-PRSx8-GFP mice (average change in MAP, 22 4 mmHg vs
10  1 mmHg, respectively; p  0.001) (Fig. 6). While signifi-
cantly increased relative to Lv-PRSx8-GFP, the sustained pressor
response in Lv-PRSx8-AT1AR mice remained reduced compared
to the AT1AR
/ (28  2 mmHg; p  0.05). The cage-switch-
stress-inducedHR (155 12 bpmvs 163 11 bpm, respectively)
and locomotor responses were similar between Lv-PRSx8-AT1AR
and Lv-PRSx8-GFP groups and significantly reduced compared
to AT1AR
/mice.
Restraint stress
Restraint stress was induced by placing mice in a tail cuff BP
restrainer. No difference in the MAP or HR responses to this
stress was observed between AT1AR
/ mice and the Lv-PRS-
GFP group, but the Lv-PRSx8-AT1AR group showed a signifi-
cantly diminished pressor response and increased tachycardia
(p 0.001) (Fig. 7).
Novel feeding stimulus
The pressor response to presentation and
eating of a novel, palatable food (almond)
was increased in Lv-PRSx8-GFP compared
to both AT1AR
/ and Lv-PRSx8-AT1AR
mice (MAP, 27  1 mmHg vs 25  3
mmHg; HR, 198  15 bpm vs 171  11
bpm) (Fig. 7). The HR response was signif-
icantly elevated in theLv-PRSx8-AT1ARand
Lv-PRSx8-GFP compared to AT1AR
/
mice (Fig. 7).
Discussion
Using several transgenic mouse models,
we demonstrated that the AT1AR is en-
dogenously expressed in RVLM C1 neu-
rons and required for the pressor response
to microinjection of AngII into this nu-
cleus. Lentiviral expression of this AT1AR
in the C1 neurons of adult AT1AR
/mice did not alter basal BP
or HR but significantly increased the sustained pressor response
to cage-switch stress toward that of AT1AR
/ mice. Lentiviral
expression of the AT1AR in C1 neurons did not alter the HR or
activity response to cage-switch stress. The effect of AT1AR ex-
pression in C1 neurons on the immediate pressor response to
cage-switch or restraint stressors or the appetitive stimulus was
more variable. These observations argue that endogenous AngII
acts on C1 neurons to modulate the BP response to aversive
stress. In addition, our results clearly link activation of the RVLM
C1 neurons to the sustained elevation of BP elicited by cage-
switch stress.
Two lines of evidence support the conclusion that RVLM C1
neurons express AT1AR endogenously. First, in a transgenic
mouse with a bacterial artificial chromosome, in which the
AT1AR promoter drives expression of GFP, transgene expression
occurs in rostral RVLMC1 neurons. These are presumptive sym-
pathetic premotor neurons. Autoradiographic and in situ hybrid-
Figure 4. A, B, Average hourly values for MAP, HR, and activity (arbitrary units) in AT1AR
/mice at Day 0 (open circles) and at Day 33 (closed circles) after RVLM microinjection of either (A)
Lv-PRSx8-AT1AR (n7) or (B) Lv-PRSx8-GFP (n5). The closedbar on the x-axis represents the dark period (active period), and the openbar represents the light period (inactive period). Error bars
indicate SEM.
Figure5. A, Groupeddata forMAPduring theday (6A.M. to6P.M.) andnight (6P.M. to6A.M.) periods atbaseline (control) and
3, 4, and 5 weeks following RVLM microinjection of either Lv-PRSx8-GFP (n 5) or Lv-PRSx8-AT1AR (n 7). B, The bar graph
shows the change in MAP observed when the values for Weeks 3, 4, and 5 are averaged and compared to baseline. Values are
mean SEM. *p 0.05.
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ization histochemical studies have
demonstrated expression of AT1R in the
RVLM of several species, including hu-
mans (Allen et al., 1988; Lenkei et al.,
1997). These approaches did not provide
the resolution or compatibility that en-
abled neurochemical characterization of
the AT1R-expressing cells. Immunohisto-
chemical approaches have been difficult
due to the low-level expression of the re-
ceptor and general issues surrounding
specificity of antibodies directed to the
AT1AR (Smith et al., 1998). The transgenic
mouse used in this study provides an
alternative approach. Our observations
concur with a previous immunohisto-
chemical study (Wang et al., 2008) and
support electrophysiological observations
in slices of RVLM that demonstrate that
AngII directly excites C1 neurons (Li and
Guyenet, 1996). While transgenic mice
represent a novel approach to examining
the distribution of proteins for which
standard approaches are problematic,
there are methodological limitations due
to potential ectopic expression. In this
study, we mapped the distribution of
GFP-expressing cells throughout the
mouse CNS and compared it to the
known distribution observed using in
vitro autoradiography (Jenkins et al.,
1997). The maps are very similar, al-
though there were a few sites where, on
the basis of autoradiography, we expected
to see GFP but didn’t. These tend to be regions of lower level
expression, such as the area postrema and parabrachial nucleus.
This may be due to reduced sensitivity or that the AT1BR may be
responsible for the majority of AT1R binding observed in some
nuclei.
Second, we used lentiviruses with the PRSx8 promoter to
drive Cre expression in the RVLM of mice containing a condi-
tional AT1AR allele. Thesemice, which showed no change in their
Figure 6. Effect of expression of AT1ARs in RVLM C1 neurons on the response to dirty-cage-switch stress. MAP and HR and
activity (arbitrary units) were measured before and for 60 min after placing each male mouse in a cage occupied previously by
anothermalemouse. Each point represents themean SEMof the average data for 10min. Gray circles areAT1AR
/mice (n
6), open circles are AT1AR
/ mice injected with Lv-PRSx8-GFP (n 5), and filled circles are AT1AR
/ mice injected with
Lv-PRSx8-AT1AR (n 7). The same color scheme applies to the bar graphs, which show average changes in each parameter over
with the initial 5 min period or the entire 60 min period compared to the control period. Plus signs denote comparison to the
AT1AR
/ mice, while asterisks denote comparison with Lv-PRSx8-GFP-injected mice. One symbol represents p 0.05, two
symbols represent p 0.01, and three symbols represent p 0.001.
Table 1. Average spectral power in low-, mid-, and high-frequency bands for MAP, HR, coherence, and gain in Lv-PRSx8-AT1A and Lv-PRSx8-GFP RVLM-microinjectedmice
assessed during the inactive period
Week 0
Lv-PRSx8-GFP
Week 0
Lv-PRSx8-AT1AR
Day 33
Lv-PRSx8-GFP
Day 33
Lv-PRSx8-AT1AR
Week 0
Lv-PRSx8-GFP vs
Lv-PRSx8-AT1AR
Day 33
Lv-PRSx8-GFP vs
Lv-PRSx8-AT1AR
Week 0 vs Day 33
Lv-PRSx8-GFP
Week 0 vs Day 33
Lv-PRSx8-AT1AR
Coherence
Low frequency 0.51 0.03 0.43 0.02 0.52 0.03 0.50 0.03 ns ns ns ns
Midfrequency 0.63 0.02 0.60 0.01 0.63 0.02 0.63 0.02 ns ns ns ns
High frequency 0.46 0.03 0.44 0.02 0.46 0.02 0.47 0.04 ns ns ns ns
Gain (bpm/mmHg)
Low frequency 12.1 1.0 9.8 1.0 13.2 1.3 12.7 1.7 ns ns ns ns
Midfrequency 19.8 1.3 16.5 1.4 19.7 1.6 18.5 1.6 ns ns ns ns
High frequency 28.6 2.0 24.3 2.0 25.8 2.8 19.8 0.9 ns ns ns ns
MAP (mmHg 2)
Low frequency 0.65 0.13 0.66 0.16 0.95 0.14 0.58 0.07 ns ns ns ns
Midfrequency 0.14 0.03 0.23 0.09 0.25 0.05 0.12 0.01 ns ns ns ns
High frequency 0.62 0.13 0.63 0.09 0.90 0.18 0.59 0.08 ns ns ns ns
Total 3.03 0.58 2.82 0.46 4.01 0.46 2.39 0.24 ns ns ns ns
HR (bpm)2
Low frequency 116 32 106 15 226 39 149 32 ns ns ns ns
Midfrequency 64.9 17 53.7 7.3 102 14 63.9 11 ns ns ns ns
High frequency 719 119 732 121 894 109 541 63 ns ns ns ns
Total 105 184 1184 176 1538 158 926 126 ns * ns ns
Data are presented as mean SEM, indicating between-animal variance. Low frequency, 0.08–0.3 Hz; midfrequency, 0.3– 0.5 Hz; high frequency, 0.5–1 Hz; total, 0–1 Hz. ns, Not significant.
*p 0.05.
2058 • J. Neurosci., February 8, 2012 • 32(6):2051–2061 Chen et al. • CNS Angiotensin, Blood Pressure, and Stress
response to RVLM microinjection of glutamate, did not show a
pressor response to microinjection of AngII. The response to
AngII was not affected by injection of Lv-PRSx8-GFP. Together,
these data strongly support the conclusion that AngII acts in the
RVLM to increase BP via the AT1AR which is endogenously ex-
pressed on C1 neurons.
The pressor response induced by aversive stressors has two
phases—an initial rapid phase reliant upon glutamatergic trans-
mission in the RVLM and a sustained phase, which partially in-
volves AngII action in the RVLM (Mayorov and Head, 2002,
2003). Blockade of RVLM AT1R attenuates the sustained cardio-
vascular response to aversive air-jet stress in conscious rabbits,
without affecting the initial response (Mayorov andHead, 2003).
Similarly, the sustained pressor response to aversive stress is di-
minished in AT1AR
/ mice, with an associated decrease in Fos
expression in RVLMneurons (Davern et al., 2009). In the current
study, cage-switch stress in AT1AR
/mice expressing AT1AR in
C1 neurons induced a sustained elevation in BP compared to
Lv-PRSx8-GFP-injected AT1AR
/mice. This mimics the BP re-
sponse to cage-switch stress in wild-type mice (Davern et al.,
2009). In contrast, the pressor response in the Lv-PRSx8-GFP-
injectedAT1AR
/mice starts to return to baseline by 20min and
has reached baseline by the end of the cage-switch test. This ob-
servation is consistent with that seen in
the AT1AR
/mice (Davern et al., 2009).
We conclude that the sustained pressor
response to cage-switch stress is depen-
dent upon AngII acting on the AT1AR in
C1 neurons. The outstanding question re-
lates to the source of the AngII that pro-
vides this activation. Unfortunately our
understanding of the biochemistry of the
brain renin–angiotensin system and the
localization of its components remains in-
complete such that this question cannot
be definitively answered.
The response of the lentiviral-injected
AT1AR
/ mice to short-term stress is
more variable, both within this study and
in comparison to results from previous
studies (Chen et al., 2009). In this study,
the initial pressor response to aversive
stress is either not altered (cage switch) or
significantly reduced (restraint) in the
Lv-PRSx8-AT1AR-expressing AT1AR
/
mice, while the pressor response to an
appetitive stimulus is slightly reduced rel-
ative to the GFP-expressing mice and not
different from the AT1AR
/ mice. In
published observations (Chen et al.,
2009), the AT1AR
/ mice showed a di-
minished response to the appetitive and
restraint stimuli compared to AT1AR
/
mice, which is not replicated here by the
Lv-PRSx8-GFP-injected mice. It is possi-
ble that GFP expression has altered the
response to restraint stress, but this is un-
likely as none of the other observations
related to the Lv-PRSx8-GFP mice show
any substantial difference compared to
AT1AR
/ mice from previous studies.
The reason for this discrepancy is not
clear and suggests caution in relation to
drawing strong conclusions about the responses to short-term
stressors.
The link between acute aversive stress and cardiovascular
events such as myocardial infarction is clearly established (Wil-
lich et al., 1993; Mittleman et al., 1995; Leor et al., 1996). There is
alsoagrowing recognition that chronic inescapableorunpredictable
stress contributes to the development of essential hypertension in
some people (Esler, 2009). The mechanisms underpinning this
involvement in hypertension remain unclear. We propose that
the sustained increase in BP induced by AngII in RVLM has
significance for understanding how exposure to repeated aversive
stressors could lead to hypertension. If BP remains elevated from
one aversive stress exposure to the next, it is possible that a tetanic
response could occur. This, combined with potential trophic ef-
fects of the elevated SNA (Hardebo, 1992; Mancia et al., 1999),
could lead to sustained elevations of BP and consequent cardio-
vascular disease.
Cage-switch stress also induced tachycardia and increases in
activity. Injection of Lv-PRSx8-AT1AR in RVLM did not alter
either of these parameters. This suggests that the tachycardia in-
duced by cage-switch stress is produced by an alternative pathway
activating cardiac sympathetic activity, or by withdrawal of car-
diac vagal activity. Cage-switch stress inmice activates neurons in
Figure7. A,B, Effect of expressionofAT1ARs inRVLMC1neurons on the short-termMAPandHR responses to restraint stress (A)
and novel food stimulus (B) in AT1AR
/ (gray symbols) and AT1AR
/mice microinjected in the RVLM with either Lv-PRSx8-
AT1AR (n7; closed circles) or Lv-PRSx8-GFP (n5; open circles). Each symbol represents anaverage (meanSEM) for each30 s
period. The bar graphs represent the average change in the measured parameters in each group. These average responses were
calculated from a 5 min control period and 5 min of each stressor (the period between the dotted lines). Plus signs denotes
comparison to the AT1AR
/mice, while asterisks denotes comparisonwith Lv-PRSx8-GFP-injectedmice. One symbol represents
p 0.05, two symbols represent p 0.01, and three symbols represet p 0.001.
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raphe pallidus (Davern et al., 2009), which is involved in the
sympathetic HR response to some stressors (Zaretsky et al.,
2003). While our studies do not provide further information
about the pathways involved in the cardiac response to aversive
stress, the lack of effect on this pathway adds considerable
strength to the specificity of our observations on the role of C1
neurons.
Appetitive stimuli induce a distinct rise in BP and HR in both
experimental animals and humans (Del Bo et al., 1985; Brosschot
and Thayer, 2003; Braesicke et al., 2005). Feeding-associated
arousal is initiated by the activation of descending inputs from
the CNS rather than the viscerosympathetic reflex responses (Di-
amond and LeBlanc, 1987; Matsukawa and Ninomiya, 1987). In
our study, presentation of a novel palatable food elicited a pressor
and tachycardic response, with only minor differences between
groups. In addition, the cardiovascular responses to the appeti-
tive stimulus are comparable to those seen in the naiveAT1AR
/
andAT1AR
/mice (Chen et al., 2009). The lack of BP difference
in the appetitive stimulus suggests that either the RVLMC1 neu-
rons or AngII is not essential to this response.
We had hypothesized that expression of AT1AR in C1 neurons
might increase resting BP in the AT1AR
/ mice. However, the
observed lack of effect, and potentially a small decrease in day-
time resting BP, is supported by previous observations. Little or
no BP change occurs in response to microinjection of AT1R an-
tagonists into the RVLM of normotensive animals under basal
conditions (Allen et al., 2009). Transgenic mice with neuronal
overexpression of the AT1AR have normal resting BP, despite
having exaggerated pressor responses to intracerebroventricular
infusion of AngII (Lazartigues et al., 2002). Thus, it seems that
under basal conditions AngII has little effect on RVLM neurons
to regulate BP. In contrast, under conditions where the AngII
input to RVLM is activated, either by physiological stimuli or in
pathological states such as hypertension, AT1R antagonists pro-
duce significant decreases in BP through inhibition of sympa-
thetic efferent activity (Allen et al., 2009). This supports the
observation that activation of the receptor, and not just increased
expression, is required for an altered phenotype.
In this study, we demonstrate that the AT1AR is expressed in
C1 neurons and required for the pressor response to AngII in this
nucleus. Furthermore, transgenic expression of the AT1AR in C1
neurons in adultAT1AR
/micemodulates the pressor response
to cage-switch stress, implicating both these cells and this recep-
tor system in the stress pathway.Of importance is the demonstra-
tion that expression of the AT1AR in C1 neurons returns the BP
response to cage-switch stress toward that of the AT1AR
/
mouse. This implies that AngII is released within the RVLM in
response to cage-switch stress and serves to sustain the pressor
response.We propose that this sustained activation of autonomic
activity could underpin the development of hypertension in-
duced by repeated aversive stressors.
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